Binovi is well-positioned to further commercialize and capitalize on the massive demand for Vision Therapy and Training For Athletes and Education.
Strong IP Portfolio
1 in 4 people on the planet have vision problems that go beyond simply not being able to read those letters on the wall and requiring a prescription.
Since the launch of Binovi, more than 800 organizations have been registered and have used the platform for vision therapy, sports vision performance.
Clients Include:
Dallas Stars (NHL)
Chicago Cubs (MLB)
Sporting KC (MLS)
Tennis Canada
Showcased During NFL Scouting Combine
Company’s Vision Therapy Products Used In:
Over 1,500 Practices
20 Countries
These organizations have created nearly 31,000 users and have completeded more than 400,000 active sessions centred around the Binovi Library list of activities, custom activities created by member organizations.
Flagship “Binovi” Is State-Of-The-Art Platform
Measures 14 Key Vision Skills
Essential For Maximizing Brain Performance
Signed Sports Vision Partnership With Eli Wilson Goaltending
World Leader In Goaltending Development
600 Active Goaltending Camp Participants
50,000 Global Aspiring Goaltenders
Announced a strategic partnership with STEM Sports
Expanded its global reseller network with a partnership with Sport-Orthèse, major European sports e-seller
Sports Performance Market is a $600 Billion Opportunity
Vision Therapy captures 3% of a $36B Yearly Vision Market today.
Vision Therapy grew by 22% in 2020 and won 4% of the $39B Yearly Market in 2020 with organic growth.
VISN’s sights are set on disrupting the sports performance industry in 2021, as we receive engagement from leaders within the human performance – sports performance industry.
The size of the sports performance market reached a value of nearly $488.5B in 2018, having grown at a compound annual growth rate (CAGR) of 4.3% since 2014, and is expected to grow at a CAGR of 5.9% to nearly $614.1B by 2021.
What is VISN?
Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance.
Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance.
Binovi Technologies Corp (TSX-V: VISN | OTCQB: BNVIF) is reshaping V Education, Vision Care, and Performance through Purposeful, Powerful Vision Training
Utilizing in-office and home-based activity protocols, the innovative Binovi platform helps optometric practices gain greater results, faster, with improved patient satisfaction in areas ranging from sports performance to binocular vision abnormalities.
In a world in which competitors are seeking an edge, Binovi vision training develops faster brains to deliver that edge.
How Does VISN Work?
Binovi combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training.
Binovi goes far beyond fixing eyes that simply can’t see a bunch of letters on an eye chart. Rather, Binovi delivers higher-performing brains by optimizing the performance of the eyes. Binovi synchronizes your eyes and your brain to deliver maximum performance for athletes and students.
Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort.
Who Uses VISN?
Binovi is currently used in over 20 countries and supported by recognized optometry leaders.
Patients: Optometrist-lead vision therapy for patients suffering from developmental issues or recovering from injury.
Optometry Professionals: Practicing optometrists and vision therapists working in development, rehabilitation, and healthy ageing.
Athletes: Optometry-backed tools to help improve sports vision performance indicators like reaction time and hand-eye coordination.
Binovi $VISN.ca $BNVIF
$EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF
Binovi Techologies Corp. is traded on the TSX.V as VISN.
Posted by AGORACOM
at 11:02 AM on Tuesday, March 16th, 2021
*Tournaments break participation and viewership records for the company *Top channel in Twitch’s popular RocketLegue category
VANCOUVER, BC, March 16, 2021 /CNW/ – TGS Esports Inc. (“TGS” or the “Company”) (TSXV: TGS) (FRA: 5RH) is pleased to announce two record-shattering weekends of white label events.
Over the weekend of March 5-7th, TGS ran four events for its partner brands, including Telcel and NorQuest College. These events had 1400+ players participating and attracted 35,000+ viewers on their TGS produced live streams, setting new participation and viewership records for the company.
The following weekend, March 12-14th, TGS ran two more events for its partner brands that attracted 96,000+ viewers, which was another new and significant participation and viewership record for TGS. Both of these streams featured the popular game title Rocket League, and both streams led Twitch’s Rocket League viewership category throughout the day.
“Brands spent over $500 million on esports events & sponsorship in 20201 and they are looking to spend their money where it has the greatest impact,” said Spiro Khouri, CEO of TGS. “We make it an easy decision for brands to spend their money with TGS.”
Posted by AGORACOM
at 10:36 AM on Tuesday, March 16th, 2021
TORONTO , March 16, 2021 /PRNewswire/ – Predictiv AI Inc. (TSXV: PAI) (OTC: INOTF) (FSE: 71TA) (” Predictiv AI ” or the ” Company “), a software and solutions provider in the artificial intelligence markets is pleased to announce its dynamic new partnership with the Waterloo Artificial Intelligence Institute (“Waterloo.AI”) at the University of Waterloo . This partnership will allow Predictiv AI’s subsidiary, AI Labs Inc. (“AI Labs”), to pursue its various innovations through leveraging Waterloo.AI as an extension of the Predictiv AI team.
The collaboration will allow access to the world’s top artificial intelligence resources, creating much greater bandwidth in ideation, research, and development of solutions for real-world problems. Predictiv AI also looks forward to participating in and supporting Waterloo.AI events and introducing other synergistic partners to the program. Beyond having access to an unparalleled talent pool of academics and their teams for research and development, the partnership also provides for round table participation amongst Waterloo.AI partners.
“We are thrilled to have Predictiv AI join as a partner with Waterloo,” said Harold Godwin , Managing Director of Waterloo.AI. “This is a very exciting time for our university and Waterloo.AI, and we are grateful for the interest and ongoing support of our partners, including our newest, Predictiv AI.”
“We are very excited and honoured to be working with one of the world’s leading artificial intelligence institutions. We will now be able to accelerate our innovations and scale our team’s productivity while learning new ways to approach projects with new and unique technologies,” said Michael Lende, CEO of Predictiv AI.
Posted by AGORACOM
at 10:31 AM on Tuesday, March 16th, 2021
Mountain Valley MD Holdings Inc.(the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce it is commencing husbandry animal trials under the supervision of The People’s Republic of Bangladesh’s Ministry of Fisheries & Livestock for the Company’s injectable solubilized Ivermectin technology, Ivectosol™ 1%.
“We are very excited to be welcoming Mountain Valley MD to The People’s Republic of Bangladesh and are proud that they have selected our country for important research projects and as a key production hub for its solubilized Ivectosol™ 1% product,” stated Bangladesh’s Foreign Minister H.E. Dr. A. K. Abdul Momen, M.P.
MVMD is working with its local partner R&G Group inside Bangladesh to quickly advance its research and development, and manufacturing capabilities inside the country.
MVMD’s Ivectosol™ 1%, a fully solubilized form of the anti-parasitic drug Ivermectin, will be tested in cattle, goat and poultry under the supervision of the Bangladesh Government’s approved and authorized laboratories and research institutes. The tests will be conducted by way of intra-muscular needleless injection of Ivectosol™ 1% in an effort to demonstrate superior pharmacokinetics in terms of CMAX (peak serum concentration that a drug achieves) and AUC (area under the curve) with advanced drug withdrawal time control, versus current commercially available forms.
The trials are scheduled to commence in early April, 2021 and are anticipated to take 30 days. The trial results are scheduled to be reviewed and approved by the Ministry of Fisheries & Livestock and Ministry of Health and will enable the Company to advance against immediate commercialization opportunities. The Company is finalizing production supply agreements with key Bangladesh pharmaceutical partners to produce its Ivectosol™ 1% for use and distribution throughout Bangladesh and as a production hub for broader global distribution. The production scheduling and pricing are currently being finalized under non-disclosure agreement (“NDA”), including securing the sufficient Ivermectin Active Pharmaceutical Ingredient (“API”) quantity for anticipated global demand.
“We’ve been extremely impressed by the speed and pace with which the Government of the People’s Republic of Bangladesh continues to provide our teams with incredible support for the testing and preparedness of an accelerated commercialization pathway for Ivectosol™ 1%,” stated Dennis Hancock, President and CEO of Mountain Valley MD. “Our pharmaceutical partners are both FDA and EU compliant and support our broader objectives to scale for global production. Securing top quality manufacturing within a competitive cost structure is critical to align with one of the core tenets of MVMD’s mission to ensure accessibility to our technology for even the most disadvantaged nations.”
Posted by AGORACOM
at 9:56 AM on Tuesday, March 16th, 2021
Victory Square received 4,411,765 common shares of Cloud Nine Web3 Technologies Inc. (CSE: CNI) at a deemed issue price of $1.36 per common share for a purchase price of $6,000,000
The share price of Cloud Nine (CSE: CNI) closed on March 15, 2021 at $1.79 per common share, valuing Victory Square’s 4,411,765 common shares at $7,897,059.35
Victory Square will have the right to dividend up to 15% of the total number of the Consideration Shares issuable hereunder to its shareholders
Company exercised 350,000 warrants in Argo Blockchain PLC (LON: ARB) for an approximate $1,488,000 gain (as at March 15th, 2021)
VANCOUVER, British Columbia, March 16, 2021 — Victory Square Technologies Inc. (“Victory Square” or the “Company“) (CSE:VST) (OTC:VSQTF) (FWB:6F6) — is pleased to announce that it has signed and closed an asset purchase agreement dated March 15, 2021 to sell certain intellectual property assets related to a development stage VPN platform (the “Acquisition”) to Cloud Nine Web3 Technologies Inc. (“Cloud Nine” )(CSE: CNI).
“We’ve spent the last 6 years connecting with and investing in some of the brightest and disruptive minds in the Technology space; quietly building up a stockpile of applications and IP while waiting for an inflection point to start unleashing these applications to market,” said Victory Square CEO Shafin Diamond Tejani.
“This 6 million sale of IP and the $1.5 million gain on Argo points to the extensive depth of the Victory Square portfolio and our ability to monetize and provide value to our shareholders.”
In consideration for the Acquisition, Victory Square received 4,411,765 common shares of Cloud Nine at a deemed issue price of $1.36 per common share for a sale price of $6,000,000.
Posted by AGORACOM-JC
at 9:05 AM on Tuesday, March 16th, 2021
Common shares are now trading on the OTCQX Best Market under the ticker symbol of HPQFF
The OTCQX Best Market is the highest market tier of OTC Markets, which operates financial markets for 11,000 U.S. and global securities
MONTREAL, March 16, 2021 — Innovative silicon solutions provider HPQ Silicon Resources Inc. (“HPQ” or the “Company”) ( TSX-V: HPQ ; FWB: UGE ; OTCQX: HPQFF ), is pleased to inform investors that its common shares are now trading on the OTCQX Best Market under the ticker symbol of HPQFF. The OTCQX Best Market is the highest market tier of OTC Markets, which operates financial markets for 11,000 U.S. and global securities. Trading on OTCQX will enhance the visibility and accessibility of the Company to U.S. investors. HPQ common shares will continue to trade on the TSX Venture Exchange under the symbol HPQ, and on the Frankfurt Stock Exchange under the symbol UGE.
Upgrading to the OTCQX Market is an important step as it provides transparent trading in our shares for our U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the U.S. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws.
“ We are pleased to have qualified to trade on the OTCQX ® Best Market from the Pink ® market today. This will make it easier for U.S. investors to discover and invest in HPQ Silicon Resources Inc, as we continue our research, development and commercialization of advanced nanoscale silicon materials, in order to remain at the forefront of innovative processes for the storage and delivery of clean renewable energy, ” said Bernard Tourillon, Chairman and CEO of HPQ Silicon Resources Inc.
Furthermore, HPQ Silicon is in the process of securing Depository Trust Company (“DTC”) eligibility for its common shares. DTC manages electronic clearing and settlement of publicly traded companies across the United States and in 131 other countries. Trading through DTC allows for cost-effective clearing and guaranteed settlement, simplifying and accelerating the settlement process of daily trades.
Posted by AGORACOM-JC
at 8:53 AM on Tuesday, March 16th, 2021
A key milestone in digitization of the modern army
KWESST extending its ATAK integration capability to other customers and OEMs
Ottawa, Ontario–(March 16, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) today announced that it has successfully achieved an important milestone under the contract announced in December 2020 for a key military customer.
This milestone entailed the integration of the Company’s TASCS (Tactical Awareness Situational Control System) IFM (Integrated Fires Module) for the 81mm Mortar Fire Control System into the Android Tactical Assault Kit (ATAK), the preeminent battlefield management system for NATO countries . As a result, the Company will now proceed to the next phase of the contract, involving live-fire trials at various U.S. military bases.
“TASCS is designed to integrate into any battlefield management application,” said Jeff MacLeod, KWESST Found, President and CEO. “However, ATAK is the foremost and ubiquitous NATO battlefield management application, therefore we view the successful integration of TASCS applications into ATAK as key to widespread adoption of our TASCS system, and are pleased to have achieved this milestone event.”
The TASCS IFM Fire Control System for the 81mm mortar is a world-first in digitizing the function of a mortar team, from the identification of the target to the aiming of the mortar. It reduces the time it takes to engage adversaries and greatly increases the precision of mortar fire. TASCS has similar application across many other firing platforms beyond just the 81mm mortar, with a world market estimated by the Company at several hundred million dollars.
The Company added that its ability to use its TASCS system as a toolset to integrate tactical applications into ATAK has attracted attention from other military customers and OEMs. “We’re discovering that many potential customers require ATAK integration help,” added Jeff MacLeod. “We have already begun assisting some, and we are currently processing about a dozen other inbound enquiries for assistance, both domestic and international. It appears that this has the potential to become a separate business line unto itself, with recurring revenue.”
Posted by AGORACOM
at 8:46 AM on Tuesday, March 16th, 2021
Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland” or the “Company“) an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles to the legal, recreational market within the Netherlands, announces it has completed the sale and import (the “Transaction“) of the Company’s high-grade consumer packaged goods (“iMicrodose Packs“) from the Netherlands to Canada under a Health Canada psilocybin import permit obtained by CCrest Laboratories Inc. in partnership with Shaman Pharma Corp.
The Transaction between Red Light Holland and the Montreal, Quebec-based cGMP lab, CCrest Laboratories, is the first of a multi-phase project to expand into the mental wellness pharmaceutical sector by demonstrating a legally compliant route for supplying raw materials containing psychoactive molecules, produced abroad by Red Light Holland, and imported into Canada.
“Today is another ground-breaking, precedent setting and defining leap forward for the entire Psychedelic sector as Red Light Holland has successfully expanded the reach of iMicrodose packs across international borders. As interest in novel psychedelic therapies increase on a daily basis, we will continue to aim to take our natural-occurring packaged psilocybin products to global markets, allowing Red Light Holland to increase our distribution and sales channels. The agreement with Shaman Pharma to utilize its partnership with CCrest Laboratories is part of Red Light Holland’s growth strategy, complementing the international groundwork which we established in the Netherlands, as one of the only legal sources for producing natural raw materials containing psilocybin,” said Todd Shapiro, Chief Executive Officer and Director of Red Light Holland. “The collaboration with Shaman Pharma, who have successfully received our iMicrodose packs on Canadian soil, simply put, is a significant day for the Company and its shareholders. We are very proud to have our Netherlands grown Magic Truffles designed for responsible use via education and information, in Canada. They’ve arrived home and Red Light Holland continues to trailblaze across the world.”
The Transaction is performed with the intent of exploring continued collaboration beyond successfully completing the shipment of Red Light Holland’s consumer packaged goods under a Health Canada import permit. The multi-phase scientific undertaking by CCrest Laboratories is planned to perform each phase of developing viable ingredients to address the demanding requirements of clinical trials, patient’s Special Access Programs, and the downstream supply of production-ready substances.
“We are delighted to build a relationship with Red Light Holland as we access the global industry for the very best of both product supply and, with recognition of their position as a market leader in establishing a supply chain from Europe to North America, the ability to meet the exacting needs of a globalized medical marketplace,” stated Alex Grenier, Chief Executive Officer of Shaman Pharma and President of CCrest Laboratories. “Today, we succeeded in demonstrating our strong ability to navigate the stringent regulatory landscape for conducting international transactions of controlled substances and setting the bar for scientific excellence. Furthermore, through this collaboration with Red Light Holland, we were pleased to find that Mr. Shapiro’s vision and ethic is well aligned with compatible long-term objectives for pioneering the psychedelic therapy sector in a manner that exceeds the most complex compliance requirements.”
Posted by AGORACOM
at 8:43 AM on Tuesday, March 16th, 2021
Chilean Metals Inc. to change its name to “Power Nickel Inc.” to reflect its focus on development of its James Bay High-Grade Nickel Copper Cobalt Palladium “Nisk” Project.
Chilean Metals’ subsidiaries currently holding the Company’s Chilean assets will be separated and spun out as a new public company with all of its existing Chilean assets and sufficient capital for one-year of operations
Chilean Metals will create a new subsidiary Consolidation Gold and Silver Inc. to be spun out as a separate public company where it will hold the option agreement on the Golden Ivan project and sufficient capital for one-year of operations
Shareholders of Chilean Metals will participate in both new public companies and retain their current ownership interest in each Company
Chilean Metals Inc.(the “Company” or “Chilean Metals”) (TSXV:CMX)(OTC PINK:CMETF)(Frankfurt:IVVI) is pleased to announce that the board of directors has approved the Company’s plans to change its name to Power Nickel Inc. and to spin-off two independent public companies to carry forward with its existing Chilean and British Colombia mining assets.
Proposed Transaction Highlights
Chilean Metals to be renamed Power Nickel Inc. and will focus its efforts on the exploration and development of the Nisk project. On February 1, 2021 Chilean Metals completed the acquisition of its option to acquire up to 80% of the Nisk project from Critical Elements Lithium Corporation (CRE)(CRECF)(F12). These estimates at the Nisk project are of a historic resource and the Company’s geologic team has not completed sufficient work to confirm a NI 43-101 compliant resource. Therefore, the estimates cannot, and should not be relied upon.
Table ‑1: Historical Resource Estimate figures for respective confidence categories at the NISK-1 deposit, After RSW Inc 2009: Resource Estimate for the NISK-1 Deposit, Lac Levac Property, Nemiscau, Québec.
The information regarding the NISK-1 deposit was derived from the technical report titled “Resource Estimate for the NISK-1 Deposit, Lac Levac Property, Nemiscau, Québec” dated December 2009. The key assumptions, parameters and methods used to prepare the mineral resource estimates described above are set out in the technical report.
The NISK property comprises a large land position (20 kilometres of strike length) with numerous high-grade intercepts outside the current resource area. Chilean is focused on expanding its current high-grade nickel-copper PGE mineralization historical resource prepared in accordance with NI 43-101, identifying additional high-grade mineralization, and developing a process to potentially produce nickel sulphates responsibly for batteries for the electric vehicles industry.
Shareholders of Chilean Metals will receive shares in the two public companies proposed to be separated out by the plan of arrangement, at ratios to be determined by tax and valuation considerations
One public company is proposed to hold all the historic assets in Chile as follows:
The 5600-hectare Tierra de Oro (TDO) property located about 70 Kms south of Copiapo. Historically about $6,000,000 has been spent exploring TDO with the most recent drill program completed and reported in January 2021 which highlighted a 2-metre section that returned 716 grams of silver and .45% copper.
The 4300-hectare Zulema property located about 50 Kms southwest from Copiapo and adjoining the Candelaria Mine1 property (Over 950 Million Tonnes Copper, Gold & Silver according to NI- 43101 2018 report on Lundin Mining site)) An exploration program at the property in 2018 highlighted a garnet magnetite skarn with multiple lenses of Copper- Magnetite mineralization. Within the skarn, copper ranged from 0.12- 1.19% Cu and between 0.05 – 0.99g/t Au.
The 9,000-hectare Palo Negro and Hornitos properties located in Region 3 about 30 Kms west of the Candelaria mine. The properties are currently the focus of a number of geophysical programs including magnetics and IP over portions of the property which have previously been highlighted to be of interest.
Assets also include a 3% NSR royalty interest on any future production from the Copaquire Cu-Mo deposit, previously sold to a subsidiary of Teck Resources Inc. (“Teck”). Under the terms of the sale agreement, Teck has the right to acquire one third of the 3% NSR for $3 million dollars at any time. The Copaquire property borders Teck’s producing Quebrada Blanca copper mine2 in Chile’s First Region.
Consolidation Gold & Silver Inc. will hold the previously purchased option to acquire the Golden Ivan project in the Golden Triangle. The Golden Triangle is host to numerous past and current mining operations and the region has reported mineral resources that total up to 67 million oz of gold, 569 million oz of silver, and 27 billion pounds of copper. Recent mineral development activity within the local area includes Ascot Resources recently funded Premier Gold mine3 (2.3 Million oz gold), which has received $105 million in project construction financing for the development of renewed operations at the historic exploited Premier Gold deposit. Other notable active projects in the local area include the neighbouring Silverado project, and Red Mountain, and Homestake projects amongst many others.4 Further to the north Pretivm’s Bruce Jack mine5 (4.2 million oz gold), and the neighboring KSM and Eskay deposits also have significant gold, silver, and copper resources that are yet to be realized.
The property hosts two known mineral showings (Gold Ore, and Magee), and a portion of the past-producing Silverado Mine, which was reportedly exploited between 1921 and 1939. These mineral showings are described to be Polymetallic veins that contain quantities of Silver, Lead, Zinc +/- Gold +/- Copper. Numerous additional mineral occurrences, showings and past-producing mines are located in the immediate areas surrounding the property, further supporting the presence of widespread mineralization in the areas.
The property is relatively underexplored. In 2018 Precision Geophysics completed an 88-line kilometre combined magnetic and gamma-ray spectrometry survey on behalf of the vendor (who optioned to Chilean Metals) Granby Gold Inc. Standard magnetic and radiometric data products were prepared and additional interpolate structural analyses were performed on the collected data. A number of areas of coincident magnetic and radiometric anomalism have been identified, additionally ‘structurally prepared’ zones are identified from the structural analysis interpolates. Such characteristics are widely regarded as favorable indicators of widespread hydrothermal alteration aka Porphyries and may aid in vectoring toward any causative source intrusions that may be located on the property. Three preliminary target areas of merit are established as a result of the survey and will be the focus of initial explorations at the site.
Shareholders of the three entities should benefit from increased focus on core opportunities that appeal to each different investor base. As Chilean Metals grew through the acquisition of Nisk and Golden Ivan, it is anticipated that the two new public companies could similarly benefit on a go-forward basis.
Company CEO and Director Mr. Terry Lynch stated, “The result of this proposed transaction will be three stand-alone companies with attractive assets focused on specific opportunities to grow and create value for their shareholders. The driving force behind the change is to communicate in a very clear way our focus on the NISK Battery Metals project. It is rare to find a project with a historical resource that we believe has a credible chance to become a mine. The electrification movement in Automobiles and Industry is growing more and more every day and this growth will be very supportive to the price curves in Nickel, Copper, Cobalt, and Palladium. We look forward to concentrating our efforts on NISK and moving it from Historical resource through the mine development process as quickly as possible.
